OMER Stock Analysis: Buy, Sell, or Hold?
OMER - Omeros Corporation
$19.27
0.64 (3.44%)
▲
5d:
+12.1%
30d:
+87.45%
90d:
+61.12%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 11, 2026 at $13.60 · last confirmed Aug 17, 2026
Strength: 7.7/10
Get Alerted When OMER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: OMER is 20.4% above its trading range ($16.00). Market expects -38.9% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: OMER is 20.4% above its trading range ($16.00). Market expects -38.9% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$55.74
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$34.61
44.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OMER is currently trading at $19.27, which is considered extended relative to its 30-day fair value range of $9.85 to $16.00. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.8) compared to its historical average (73.8). Remarkably, the market is currently pricing in an annual earnings decline of 38.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OMER is in a strong uptrend. The price is approaching resistance at $19.58. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: OMER scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $33.00 (+71.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OMER is in a strong uptrend. The price is approaching resistance at $19.58. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: OMER scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $33.00 (+71.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.85 -
$16.00
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
Protect Your Profits
OMER is technically overbought (RSI 86). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+20.4% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- BULLISH: Trading 71.3% below Wall St target ($33.00)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.85 -
$16.00
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$13.00
Resistance Level
$19.58
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.83
Wall Street Target
$33.00
(+71.3%)
Revenue Growth (YoY)
14.9%
Profit Margin
324.9%
Valuation Discount vs History
-38.9% cheaper
PE vs Historical
16.8 vs 73.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-38.9%
(market-implied from PE analysis)
1-Year Target
$17.34
(-10%)
2-Year Target
$15.61
(-19%)
3-Year Target
$14.05
(-27%)
3-Yr Target (if PE normalizes)
(PE: 17→74)
$61.60
(+220%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 73.5%)
$77.56
(+303%)
Base:
(SPY PE: 16.8, Growth: 73.5%)
$65.04
(+238%)
Bear:
(PE: 14.3, Growth: 73.5%)
$55.28
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 11.16 | Current EPS (TTM): $1.67
Bull Case
$14.05
(-27%)
Analyst growth -31.4%, PE expands to 12.3
Base Case
$12.77
(-34%)
Market implied -31.4%, PE stable at 11.2
Bear Case
$12.67
(-34%)
Severe decline -20.0%, PE contracts to 9.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.8 to 73.8
Stabilization Target:
$84.50
(+338.5%)
PE Expansion Potential:
+338.5%
Share & Embed Analysis
Last updated: August 23, 2026 8:11 PM ET
Data refreshes hourly during market hours. Next update: 9:11 PM
Data refreshes hourly during market hours. Next update: 9:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OMER showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 40 SELL |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 42 HOLD |
Advanced OMER Option Strategies
Professional options setups generated by AI based on today's OMER price and gamma walls.
